Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingfeng He

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Pakistan Journal of Pharmaceutical Sciences|August 29, 2018
Hypolipidemic and antioxidant potential of bitter gourd (Momordica charantia L.) leaf in mice fed on a high-fat dietQingfeng He, Yanjie Li, Hong Li, et al.
Drug Design, Development and Therapy|March 19, 2024
Model-Informed Precision Dosing of Isoniazid: Parametric Population Pharmacokinetics Model RepositoryGehang Ju, Xin Liu, Wenyu Yang, et al.
Journal of Pharmaceutical Sciences|June 10, 2024
Physiologically Based Pharmacokinetic Modeling and Clinical Extrapolation for Topical Application of Pilocarpine on Eyelids: A Comprehensive StudyJiaying Lin, Fengjiao Bu, Dan Wu, et al.
Frontiers in Pharmacology|June 1, 2022
Application of Physiologically Based Pharmacokinetic Modeling in Preclinical Studies: A Feasible Strategy to Practice the Principles of 3RsYawen Yuan, Qingfeng He, Shunguo Zhang, et al.
Parasitology Research|September 21, 2010
Identification and characterization of a serine protease inhibitor with two trypsin inhibitor-like domains from the human hookworm Ancylostoma duodenaleXian Jin, Li Deng, Hui Li, et al.
The AAPS Journal|May 2, 2025
An Ocular Exposure Prediction for Topical Atropine in Human Using Physiologically Based Pharmacokinetic ModelingAole Zheng, Tian Han, Fengjiao Bu, et al.
Pharmaceutics|July 29, 2023
Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and ValganciclovirWenyu Yang, Wenyao Mak, Amanda Gwee, et al.
Journal of Affective Disorders|November 10, 2023
Escitalopram population pharmacokinetics and remedial strategies based on CYP2C19 phenotypeXin Liu, Gehang Ju, Xinyi Huang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 29, 2023
Prediction of Drug-Drug Interactions with Ensartinib as a Time-Dependent CYP3A Inhibitor Using Physiologically Based Pharmacokinetic ModelXiaowen Wang, Yiqun Yu, Hongrui Liu, et al.
British Journal of Clinical Pharmacology|August 2, 2025
Cost-utility analysis of sotagliflozin for heart failure patients with diabetes in ChinaXinyue Zhang, Fangyi Qian, Zhen Feng, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Pakistan Journal of Pharmaceutical Sciences|August 29, 2018
Hypolipidemic and antioxidant potential of bitter gourd (Momordica charantia L.) leaf in mice fed on a high-fat dietQingfeng He, Yanjie Li, Hong Li, et al.
Drug Design, Development and Therapy|March 19, 2024
Model-Informed Precision Dosing of Isoniazid: Parametric Population Pharmacokinetics Model RepositoryGehang Ju, Xin Liu, Wenyu Yang, et al.
Journal of Pharmaceutical Sciences|June 10, 2024
Physiologically Based Pharmacokinetic Modeling and Clinical Extrapolation for Topical Application of Pilocarpine on Eyelids: A Comprehensive StudyJiaying Lin, Fengjiao Bu, Dan Wu, et al.
Frontiers in Pharmacology|June 1, 2022
Application of Physiologically Based Pharmacokinetic Modeling in Preclinical Studies: A Feasible Strategy to Practice the Principles of 3RsYawen Yuan, Qingfeng He, Shunguo Zhang, et al.
Parasitology Research|September 21, 2010
Identification and characterization of a serine protease inhibitor with two trypsin inhibitor-like domains from the human hookworm Ancylostoma duodenaleXian Jin, Li Deng, Hui Li, et al.
The AAPS Journal|May 2, 2025
An Ocular Exposure Prediction for Topical Atropine in Human Using Physiologically Based Pharmacokinetic ModelingAole Zheng, Tian Han, Fengjiao Bu, et al.
Pharmaceutics|July 29, 2023
Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and ValganciclovirWenyu Yang, Wenyao Mak, Amanda Gwee, et al.
Journal of Affective Disorders|November 10, 2023
Escitalopram population pharmacokinetics and remedial strategies based on CYP2C19 phenotypeXin Liu, Gehang Ju, Xinyi Huang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 29, 2023
Prediction of Drug-Drug Interactions with Ensartinib as a Time-Dependent CYP3A Inhibitor Using Physiologically Based Pharmacokinetic ModelXiaowen Wang, Yiqun Yu, Hongrui Liu, et al.
British Journal of Clinical Pharmacology|August 2, 2025
Cost-utility analysis of sotagliflozin for heart failure patients with diabetes in ChinaXinyue Zhang, Fangyi Qian, Zhen Feng, et al.
Pageof 7